| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $272.39M | - | |
| Dir | 390.7K | $89.95M | - | |
| CEO | 152.2K | $35.04M | - | |
| VP | 72.6K | $16.72M | - | |
| CFO | 59.6K | $13.72M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2016 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $150.00 | $150,000.00 | -0.3% | |
| Aug 9, 2016 | Cox Russell J. | EVP &COO | Sell | 4,000 | $148.66 | $594,640.00 | -7.3% | |
| Jul 15, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 100 | $142.43 | $14,243.00 | -0.6% | |
| Jul 13, 2016 | Smith Karen L. | Global Head Of R&D And CMO | Buy | 580 | $143.63 | $83,304.82 | +4.5% | |
| Jun 15, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 100 | $149.64 | $14,964.00 | -0.6% | |
| Jun 13, 2016 | Smith Karen L. | Global Head Of R&D And CMO | Buy | 557 | $149.61 | $83,335.11 | +4.5% | |
| May 24, 2016 | Mulligan Seamus | Director | Sell | 27,968 | $150.29 | $4,203,338.90 | -0.6% | |
| May 16, 2016 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 100 | $145.20 | $14,520.00 | -0.6% | |
| May 16, 2016 | Riedel Norbert G63 | Director | Sell | 644 | $145.20 | $93,508.80 | -13.2% | |
| May 16, 2016 | McSharry Heather Ann61 | Director | Sell | 697 | $145.20 | $101,204.40 | -11.4% |